Could a patent get in between you and a Covid-19 test? Yes
Share
In 2001, the United States faced a credible threat of an anthrax outbreak, yet Bayer refused to license its patents on ciprofloxacin (Cipro), the most effective antibiotic treatment for anthrax, to competitors, even as Bayer itself struggled to supply the nation’s antibiotic stockpile.Featured Publications
Low-Energy Fridays: Turn Down (the Power) for What?
California and Other States Threaten to Derail the AI Revolution
Organizations Oppose Proposals to Increase Farm Subsidy Reference Prices
Farm Bill Drafts Prioritize the Unnecessary and Unaffordable